In fact, a variety of cancers have been associated with overexpression of CDC25A, including breast, liver, esophageal, endometrial, and colorectal cancers, as well as non-Hodgkin’s lymphoma (Kristjánsdóttir and Rudolph, 2004; Boutros et al., 2007). Here, CDC25A is linked to colorectal cancer.